Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors

Renae C. Streblow, Alicia J. Dafferner, Marilu Nelson, Mavis Fletcher, William W. West, Rachel K. Stevens, Zoran Gatalica, Deborah Novak, Julia A. Bridge

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Traditional cytogenetic studies of ovarian stromal tumors are few, although trisomy 12 has been frequently documented with fluorescence in situ hybridization (FISH). In the current study, karyotypic analysis of four ovarian stromal tumors and a review of the literature suggest that numerical abnormalities of chromosomes 4 and 9 might also be important, possibly as secondary changes. To determine the frequency of 4, 9, and 12 aneuploidy in a larger group of ovarian tumors, FISH studies were performed on eight fibromas, three thecomas, one fibrothecoma, and five cellular fibromas. Trisomy 12 was identified in all five cellular fibromas as well as in two fibromas and the fibrothecoma. Gain of chromosome 9 was confined to the cellular fibromas. Loss of chromosomes 4 and/or 9 was prominent in the fibromas. These findings confirm the presence of trisomy 12 as a nonrandom chromosomal abnormality in ovarian stromal tumors. Moreover, these conventional and molecular cytogenetic data indicate that gain of chromosome 9 in addition to gain of chromosome 12 is prominent in cellular fibroma. In contrast, loss of chromosomes 4 and/or 9 are recurrent in fibroma. In summary, imbalances of chromosomes 4 and 9 appear to represent important secondary abnormalities in the thecoma-fibroma ovarian tumor group.

Original languageEnglish (US)
Pages (from-to)135-140
Number of pages6
JournalCancer genetics and cytogenetics
Volume178
Issue number2
DOIs
StatePublished - Oct 15 2007

Fingerprint

Thecoma
Chromosomes, Human, Pair 12
Chromosomes, Human, Pair 9
Chromosomes, Human, Pair 4
Fibroma
Neoplasms
Trisomy
Fluorescence In Situ Hybridization
Cytogenetics
Ovarian Fibromata
Aneuploidy
Chromosome Aberrations

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Streblow, R. C., Dafferner, A. J., Nelson, M., Fletcher, M., West, W. W., Stevens, R. K., ... Bridge, J. A. (2007). Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors. Cancer genetics and cytogenetics, 178(2), 135-140. https://doi.org/10.1016/j.cancergencyto.2007.07.009

Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors. / Streblow, Renae C.; Dafferner, Alicia J.; Nelson, Marilu; Fletcher, Mavis; West, William W.; Stevens, Rachel K.; Gatalica, Zoran; Novak, Deborah; Bridge, Julia A.

In: Cancer genetics and cytogenetics, Vol. 178, No. 2, 15.10.2007, p. 135-140.

Research output: Contribution to journalArticle

Streblow, RC, Dafferner, AJ, Nelson, M, Fletcher, M, West, WW, Stevens, RK, Gatalica, Z, Novak, D & Bridge, JA 2007, 'Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors', Cancer genetics and cytogenetics, vol. 178, no. 2, pp. 135-140. https://doi.org/10.1016/j.cancergencyto.2007.07.009
Streblow, Renae C. ; Dafferner, Alicia J. ; Nelson, Marilu ; Fletcher, Mavis ; West, William W. ; Stevens, Rachel K. ; Gatalica, Zoran ; Novak, Deborah ; Bridge, Julia A. / Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors. In: Cancer genetics and cytogenetics. 2007 ; Vol. 178, No. 2. pp. 135-140.
@article{34eac317f685417a9e8f40d5b9074db3,
title = "Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors",
abstract = "Traditional cytogenetic studies of ovarian stromal tumors are few, although trisomy 12 has been frequently documented with fluorescence in situ hybridization (FISH). In the current study, karyotypic analysis of four ovarian stromal tumors and a review of the literature suggest that numerical abnormalities of chromosomes 4 and 9 might also be important, possibly as secondary changes. To determine the frequency of 4, 9, and 12 aneuploidy in a larger group of ovarian tumors, FISH studies were performed on eight fibromas, three thecomas, one fibrothecoma, and five cellular fibromas. Trisomy 12 was identified in all five cellular fibromas as well as in two fibromas and the fibrothecoma. Gain of chromosome 9 was confined to the cellular fibromas. Loss of chromosomes 4 and/or 9 was prominent in the fibromas. These findings confirm the presence of trisomy 12 as a nonrandom chromosomal abnormality in ovarian stromal tumors. Moreover, these conventional and molecular cytogenetic data indicate that gain of chromosome 9 in addition to gain of chromosome 12 is prominent in cellular fibroma. In contrast, loss of chromosomes 4 and/or 9 are recurrent in fibroma. In summary, imbalances of chromosomes 4 and 9 appear to represent important secondary abnormalities in the thecoma-fibroma ovarian tumor group.",
author = "Streblow, {Renae C.} and Dafferner, {Alicia J.} and Marilu Nelson and Mavis Fletcher and West, {William W.} and Stevens, {Rachel K.} and Zoran Gatalica and Deborah Novak and Bridge, {Julia A.}",
year = "2007",
month = "10",
day = "15",
doi = "10.1016/j.cancergencyto.2007.07.009",
language = "English (US)",
volume = "178",
pages = "135--140",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Imbalances of chromosomes 4, 9, and 12 are recurrent in the thecoma-fibroma group of ovarian stromal tumors

AU - Streblow, Renae C.

AU - Dafferner, Alicia J.

AU - Nelson, Marilu

AU - Fletcher, Mavis

AU - West, William W.

AU - Stevens, Rachel K.

AU - Gatalica, Zoran

AU - Novak, Deborah

AU - Bridge, Julia A.

PY - 2007/10/15

Y1 - 2007/10/15

N2 - Traditional cytogenetic studies of ovarian stromal tumors are few, although trisomy 12 has been frequently documented with fluorescence in situ hybridization (FISH). In the current study, karyotypic analysis of four ovarian stromal tumors and a review of the literature suggest that numerical abnormalities of chromosomes 4 and 9 might also be important, possibly as secondary changes. To determine the frequency of 4, 9, and 12 aneuploidy in a larger group of ovarian tumors, FISH studies were performed on eight fibromas, three thecomas, one fibrothecoma, and five cellular fibromas. Trisomy 12 was identified in all five cellular fibromas as well as in two fibromas and the fibrothecoma. Gain of chromosome 9 was confined to the cellular fibromas. Loss of chromosomes 4 and/or 9 was prominent in the fibromas. These findings confirm the presence of trisomy 12 as a nonrandom chromosomal abnormality in ovarian stromal tumors. Moreover, these conventional and molecular cytogenetic data indicate that gain of chromosome 9 in addition to gain of chromosome 12 is prominent in cellular fibroma. In contrast, loss of chromosomes 4 and/or 9 are recurrent in fibroma. In summary, imbalances of chromosomes 4 and 9 appear to represent important secondary abnormalities in the thecoma-fibroma ovarian tumor group.

AB - Traditional cytogenetic studies of ovarian stromal tumors are few, although trisomy 12 has been frequently documented with fluorescence in situ hybridization (FISH). In the current study, karyotypic analysis of four ovarian stromal tumors and a review of the literature suggest that numerical abnormalities of chromosomes 4 and 9 might also be important, possibly as secondary changes. To determine the frequency of 4, 9, and 12 aneuploidy in a larger group of ovarian tumors, FISH studies were performed on eight fibromas, three thecomas, one fibrothecoma, and five cellular fibromas. Trisomy 12 was identified in all five cellular fibromas as well as in two fibromas and the fibrothecoma. Gain of chromosome 9 was confined to the cellular fibromas. Loss of chromosomes 4 and/or 9 was prominent in the fibromas. These findings confirm the presence of trisomy 12 as a nonrandom chromosomal abnormality in ovarian stromal tumors. Moreover, these conventional and molecular cytogenetic data indicate that gain of chromosome 9 in addition to gain of chromosome 12 is prominent in cellular fibroma. In contrast, loss of chromosomes 4 and/or 9 are recurrent in fibroma. In summary, imbalances of chromosomes 4 and 9 appear to represent important secondary abnormalities in the thecoma-fibroma ovarian tumor group.

UR - http://www.scopus.com/inward/record.url?scp=35348860152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348860152&partnerID=8YFLogxK

U2 - 10.1016/j.cancergencyto.2007.07.009

DO - 10.1016/j.cancergencyto.2007.07.009

M3 - Article

VL - 178

SP - 135

EP - 140

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -